Insiders · NRXP

NRXP insider transactions

NRX Pharmaceuticals Inc. (NRXP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NRXP

• 111d
  SEC Form 4 filed by Chief Operating Officer Casper Joseph Michael

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 111d
  SEC Form 3 filed by new insider Casper Joseph Michael

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 271d
  SEC Form 4 filed by Chairman and Chief Scientist Javitt Jonathan C

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 271d
  SEC Form 4 filed by Director Mcbride Dennis

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 271d
  SEC Form 4 filed by Director Hurvitz Chaim

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 271d
  SEC Form 4 filed by Director Flynn Patrick John

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 292d
  New insider B Group, Inc. claimed ownership of 3,000,000 shares (SEC Form 3)

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 482d
  SEC Form 4 filed by Chief Financial Officer Abrams Michael S

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 538d
  Chairman and Chief Scientist Javitt Jonathan C bought $46,800 worth of shares (40,000 units at $1.17), increasing direct ownership by 90% to 84,634 units (SEC Form 4)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 563d
  SEC Form 3 filed by new insider Abrams Michael S

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 712d
  SEC Form 3 filed by new insider Mcbride Dennis

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 874d
  SEC Form 3 filed by new insider Rehnquist Janet

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 993d
  SEC Form 3 filed by new insider Narido Richard Clavano

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1002d
  SEC Form 4: Gorovitz Aaron bought $11,196 worth of shares (35,000 units at $0.32)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1002d
  SEC Form 4: Hurvitz Chaim bought $20,125 worth of shares (70,000 units at $0.29), increasing direct ownership by 14% to 570,000 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1021d
  SEC Form 4: Javitt Jonathan C bought $64,400 worth of shares (200,000 units at $0.32), increasing direct ownership by 137% to 346,332 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1210d
  SEC Form 5: Javitt Jonathan C gifted 300,000 shares

  5 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1268d
  SEC Form 4: Willard Stephen H bought $58,500 worth of shares (50,000 units at $1.17)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1268d
  SEC Form 4: Van Voorhees Seth bought $33,000 worth of shares (30,000 units at $1.10), increasing direct ownership by 184% to 46,337 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1268d
  SEC Form 4: Van Voorhees Seth bought $18,215 worth of shares (16,337 units at $1.11) (Amendment)

  4/A - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1277d
  SEC Form 4: Javitt Jonathan C sold $400,000 worth of shares (400,000 units at $1.00)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1285d
  SEC Form 4: Javitt Daniel C. sold $33,352 worth of shares (22,171 units at $1.50) as part of a pre-agreed trading plan

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1288d
  SEC Form 4: Flynn Patrick John bought $14,662 worth of shares (11,750 units at $1.25)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1289d
  SEC Form 4: Van Voorhees Seth bought $18,215 worth of shares (16,337 units at $1.11)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1293d
  SEC Form 4: Hurvitz Chaim bought $514,905 worth of shares (500,000 units at $1.03) (Amendment)

  4/A - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1294d
  SEC Form 4 filed by Gorovitz Aaron

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1294d
  SEC Form 4 filed by Glied Sharon

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1294d
  SEC Form 4 filed by Flynn Patrick John

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1295d
  SEC Form 4: Hurvitz Chaim bought $514,905 worth of shares (500,000 units at $1.03)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1298d
  SEC Form 4: Javitt Daniel C. sold $171,138 worth of shares (166,737 units at $1.03) as part of a pre-agreed trading plan

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1301d
  SEC Form 4: Javitt Daniel C. sold $49,510 worth of shares (49,200 units at $1.01) as part of a pre-agreed trading plan

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1406d
  SEC Form 4: Javitt Daniel C. sold $791,433 worth of shares (784,063 units at $1.01)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1417d
  SEC Form 3: New insider Willard Stephen H claimed ownership of 1,000,000 units of Restricted Common Stock

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1434d
  SEC Form 4: Javitt Daniel C. gifted 2,000,000 shares

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1440d
  SEC Form 3 filed by new insider Van Voorhees Seth

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1462d
  SEC Form 4: Javitt Daniel C. sold $303,910 worth of shares (445,712 units at $0.68)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1468d
  SEC Form 4: Javitt Jonathan C bought $58,000 worth of shares (100,000 units at $0.58), increasing direct ownership by 216% to 146,332 units (Amendment)

  4/A - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1468d
  SEC Form 4: Javitt Jonathan C bought $5,800,000 worth of shares (100,000 units at $58.00), increasing direct ownership by 216% to 146,332 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1537d
  SEC Form 3 filed by new insider Strassberg Ira S

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1551d
  SEC Form 4 filed by Besthof Robert

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1679d
  SEC Form 4: Mcmaster Herbert Raymond exercised 18,300 shares at a strike of $2.22

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1679d
  SEC Form 4: Javitt Daniel C. gifted 869,188 shares

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1679d
  SEC Form 4: Daigneault Alessandra exercised 58,979 shares at a strike of $3.07 and sold $442,004 worth of shares (33,715 units at $13.11), increasing direct ownership by 400% to 31,584 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1679d
  SEC Form 4: Besthof Robert exercised 63,710 shares at a strike of $0.20 and sold $470,400 worth of shares (40,000 units at $11.76)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1679d
  SEC Form 3 filed by new insider Mcmaster Herbert Raymond

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Troy Daniel was granted 43,093 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Javitt Jonathan C was granted 14,817,329 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Javitt Daniel C. was granted 13,971,864 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Hurvitz Chaim was granted 1,644,793 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Gorovitz Aaron was granted 41,686 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Glied Sharon was granted 13,168 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4 filed by Fricker William

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Flynn Patrick John was granted 432,750 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4: Daigneault Alessandra was granted 6,320 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 4 filed by Besthof Robert

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 3 filed by Javitt Jonathan C

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 3 filed by Troy Daniel

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 3 filed by Javitt Daniel C.

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 3 filed by Gorovitz Aaron

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1824d
  SEC Form 3 filed by Hurvitz Chaim

  3 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)